A Multi-Center, Randomized, Double-Blind, 12 Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RO5285119 in Individuals with Autism Spectrum Disorders (ASD)

Administered By

Psychiatry, Child & Family Mental Health & Community Psychiatry

Awarded By

Roche Biomedical Laboratories

Contributors

Chandrasekhar, Tara Investigator
Sikich, Linmarie Principal Investigator

Start/End

January 26, 2016 - February 28, 2018